Identifying patients with Fibromuscular Dysplasia (FMD) at the international level will have considerable value for understanding the epidemiology, clinical manifestations and susceptible genes in this arterial disease, but also for identifying eligible patients in clinical trials or cohorts. We present a two-step methodology to create a general semantic interoperability framework allowing access and comparison of distributed data over various nations, languages, formats and databases.The first step is to develop a pivot multidimensional model based on a core dataset to harmonize existing heterogeneous data sources. The second step is to align the model to additional data, semantically related to FMD and collected currently in various regis...
AIMS: Since December 2015, the European/International Fibromuscular Dysplasia (FMD) Registry enrolle...
International audienceBackground: The relevance of registries as a key component for developing clin...
The main objectives of this expert consensus are to raise awareness about fibromuscular dysplasia, w...
Identifying patients with Fibromuscular Dysplasia (FMD) at the international level will have conside...
The SIR-FMD project is a partnership between the Department of Genetics and Reference Centre for Rar...
This article is a comprehensive document on the diagnosis and management of fibromuscular dysplasia ...
This article is a comprehensive document on the diagnosis and management of fibromuscular dysplasia ...
Background: Fibromuscular dysplasia (FMD) is an idiopathic, non-inflammatory, non-atherosclerotic va...
Facioscapulohumeral dystrophy (FSHD) is a rare genetic disease that has been described more than a h...
Aims : Since December 2015, the European/International Fibromuscular Dysplasia (FMD) Registry enroll...
Since December 2015, the European/International Fibromuscular Dysplasia (FMD) Registry enrolled 1022...
Abstract Background The Italian Clinical network for FSHD (ICNF) has established the Italian Nationa...
The BIND project is a EU-funded project that attempts to improve the characterisation of brain invol...
AIMS: Since December 2015, the European/International Fibromuscular Dysplasia (FMD) Registry enrolle...
International audienceBackground: The relevance of registries as a key component for developing clin...
The main objectives of this expert consensus are to raise awareness about fibromuscular dysplasia, w...
Identifying patients with Fibromuscular Dysplasia (FMD) at the international level will have conside...
The SIR-FMD project is a partnership between the Department of Genetics and Reference Centre for Rar...
This article is a comprehensive document on the diagnosis and management of fibromuscular dysplasia ...
This article is a comprehensive document on the diagnosis and management of fibromuscular dysplasia ...
Background: Fibromuscular dysplasia (FMD) is an idiopathic, non-inflammatory, non-atherosclerotic va...
Facioscapulohumeral dystrophy (FSHD) is a rare genetic disease that has been described more than a h...
Aims : Since December 2015, the European/International Fibromuscular Dysplasia (FMD) Registry enroll...
Since December 2015, the European/International Fibromuscular Dysplasia (FMD) Registry enrolled 1022...
Abstract Background The Italian Clinical network for FSHD (ICNF) has established the Italian Nationa...
The BIND project is a EU-funded project that attempts to improve the characterisation of brain invol...
AIMS: Since December 2015, the European/International Fibromuscular Dysplasia (FMD) Registry enrolle...
International audienceBackground: The relevance of registries as a key component for developing clin...
The main objectives of this expert consensus are to raise awareness about fibromuscular dysplasia, w...